Picture of Medacta SA logo

MOVE — Medacta SA News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareBalancedMid CapFalling Star

Brief: Medacta Receives FDA Approval For M-Vizion

May 13 (Reuters) - MEDACTA GROUP SA  MOVE.S :
    * SAID ON TUESDAY IT RECEIVED FDA APPROVAL FOR M-VIZION
FEMORAL
REVISION SYSTEM EXTENSION FOR HIP ARTHROPLASTY AND ITS LONG
HUMERAL DIAPHYSIS FOR SHOULDER JOINT REPLACEMENT

Source text for Eikon:  ID:nEQ2Q9Vc0a 
Further company coverage:  MOVE.S  
   


 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))

Recent news on Medacta SA

See all news